Rus H G, Cucuianu A M, Galea F, Cristea A, Uza G, Cucuianu M
Med Interne. 1985 Oct-Dec;23(4):271-6.
When compared to values obtained in 24 age-matched normal weight normolipidemic control subjects, plasma fibronectin level was not significantly changed in the 28 patients with peripheral arterial disease, although endothelial cell-derived factor VIII related antigen was found to be obviously increased. On the other hand the 15 patients with obliterative atherosclerosis of the lower limbs who were hyperlipidemic (mainly hypertriglyceridemic) displayed a plasma fibronectin level (46.3 +/- 2.8 mg/dl) which was higher than the mean values recorded in both control subjects (36.2 +/- 1.66 mg/dl) and in normolipidemic patients with peripheral arterial disease (34.5 +/- 4.14 mg/dl). The results suggest that an increased level of plasma fibronectin should be connected rather to a peculiar pattern of hepatic protein synthesis occurring in overweight and hypertriglyceridemic subjects than to a release of this glycoprotein from an ongoing arterial lesion.
与24名年龄匹配的正常体重、血脂正常的对照受试者所测得的值相比,28名外周动脉疾病患者的血浆纤连蛋白水平没有显著变化,尽管发现内皮细胞衍生的因子VIII相关抗原明显增加。另一方面,15名患有下肢闭塞性动脉粥样硬化且血脂异常(主要是高甘油三酯血症)的患者的血浆纤连蛋白水平(46.3±2.8mg/dl)高于对照受试者(36.2±1.66mg/dl)和血脂正常的外周动脉疾病患者(34.5±4.14mg/dl)的平均值。结果表明,血浆纤连蛋白水平升高应更多地与超重和高甘油三酯血症患者肝脏蛋白质合成的特殊模式有关,而不是与这种糖蛋白从正在发生的动脉病变中释放有关。